RBGLY

Reckitt Benckiser Group plc [RBGLY] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

RBGLY Stock Summary

Top 10 Correlated ETFs

RBGLY


Top 10 Correlated Stocks

RBGLY


In the News

10:46 28 Mar 2024 RBGLY

Could Reckitt spin out baby formula wing following Enfamil crisis?

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB)'s shares continue to suffer amid a series of legal challenges related to its baby formula products. The company is facing litigation and significant financial penalties due to allegations surrounding the safety and marketing of its infant nutrition products.

10:53 28 Mar 2024 RBGLY

Reckitt Benckiser sees modest bounce following $7.1 billion market-cap wipeout

Reckitt Benckiser saw modest gains on Monday, following the share-price slide that erased some £5.6 billion ($7.1 billion) of market value.

03:02 28 Mar 2024 RBGLY

Enfamil maker vows to fight $60 million baby-formula verdict

Reckitt Beckinser Group said Friday it will seek to overturn a court ruling this week that awarded $60 million in damages to the family of a baby that died after being fed Enfamil infant formula, made by the British conglomerate's Mead Johnson Nutrition unit.

05:52 28 Mar 2024 RBGLY

Reckitt unit hit with $60 million verdict in Enfamil baby formula case in Illinois

An Illinois jury has ordered Reckitt Benckiser unit Mead Johnson to pay $60 million to the mother of a premature baby who died of an intestinal disease after being fed the company's Enfamil baby formula.

06:38 28 Mar 2024 RBGLY

Reckitt Benckiser Group plc (RBGPF) Q4 2023 Earnings Call Transcript

Reckitt Benckiser Group plc (RBGPF) Q4 2023 Earnings Call Transcript

06:27 28 Mar 2024 RBGLY

Reckitt Benckiser shares drop 11% after sales miss and Middle East 'compliance issues'

Shares in the Nurofen maker Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) fell 11% with the market spooked by its fourth-quarter sales miss and a £55 million revenue hit related to compliance issues at two of its Middle East operations. At 11.05 am, the stock was off 654p at 5,184p after the company revealed the trading drag was the result of lower-than-expected demand for cold and flu remedies and voluntary recall of its Nutramigen infant formula.

03:15 28 Mar 2024 RBGLY

Reckitt shares tumble 7% on Q4 miss and revenue restatement

Reckitt Benckiser Group shares opened 7% lower after the Anglo-Dutch consumer products group's fourth-quarter performance fell short of expectations, and an understatement in trade spend that affected its full-year net revenue figure. This underperformance was attributed to reduced sales of cold and flu products during the season.

02:19 28 Mar 2024 RBGLY

Reckitt posts like-for-like net sales drop as fewer people buy flu medication

Consumer goods group Reckitt missed fourth-quarter like-for-like net sales expectations, it said on Wednesday, citing declining sales of cold and flu season products.

10:43 28 Mar 2024 RBGLY

Just Eat, Reckitt Benckiser, Taylor Wimpey in focus on Wednesday

Any hopes that Taylor Wimpey might 'surprise on the upside' have seemingly been dashed by the CMA probe announced this week

08:44 28 Mar 2024 RBGLY

Reckitt Beckinser's volumes key in next week's update

Reckitt Benckiser needs to deliver improving volumes when it reports next week, according to Mark Britzman. “Third-quarter results disappointed and the concern remains that consumers have yet to fully digest higher prices,” he adds.

RBGLY Financial details

Company Rating
Buy
Market Cap
39.2B
Income
3.25B
Revenue
25.9B
Book val./share
-
Cash/share
-
Dividend
0.46
Dividend %
3.27%
Employees
40K
Optionable
No
Shortable
Yes
Earnings
24 Jul 2024
P/E
16.99
Forward P/E
15.7
PEG
0.29
P/S
2.75
P/B
4.19
P/C
-
P/FCF
20.34
Quick Ratio
0.14
Current Ratio
0.63
Debt / Equity
0.98
LT Debt / Equity
0.78
-
-
EPS (TTM)
4.53
EPS next Y
0.71
EPS next Q
-
EPS this Y
246.97%
EPS next Y
-84.43%
EPS next 5Y
-81.79%
EPS last 5Y
NAN%
Revenue last 5Y
2.6%
Revenue Q/Q
-3.83%
EPS Q/Q
-67.63%
-
-
-
-
SMA20
-22.54%
SMA50
-21.89%
SMA100
-18.86%
Inst Own
0.12%
Inst Trans
0.97%
ROA
8%
ROE
28%
ROC
0.16%
Gross Margin
58%
Oper. Margin
22%
Profit Margin
16%
Payout
54%
Shs Outstand
3.54B
Shs Float
713.35M
-
-
-
-
Target Price
-
52W Range
10.66-16.6
52W High
-30.31%
52W Low
+11.5%
RSI
32.2
Rel Volume
1.34
Avg Volume
885.63K
Volume
1.19M
Perf Week
-4.13%
Perf Month
-22.78%
Perf Quarter
-19.9%
Perf Half Y
-21.15%
-
-
-
-
Beta
0.066
-
-
Volatility
0.14%, 1.42%
Prev Close
2.39%
Price
11.15
Change
1.64%

RBGLY Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.633.943.714.0720.38
Net income per share
-0.780.33-0.010.662.29
Operating cash flow per share
0.40.990.480.673.68
Free cash flow per share
0.270.850.350.553.05
Cash per share
0.390.460.350.331.94
Book value per share
2.642.562.072.6611.79
Tangible book value per share
-4.19-3.89-3.2-3.025.43
Share holders equity per share
2.642.562.072.6611.79
Interest debt per share
3.533.072.752.5712.04
Market cap
44.24B47.13B46.27B41.54B7.74B
Enterprise value
54.89B56.04B54.57B49.27B14.89B
P/E ratio
-15.9639.7-889.7617.834.71
Price to sales ratio
3.443.373.52.870.53
POCF ratio
31.3513.427.2617.332.94
PFCF ratio
45.715.5437.121.263.54
P/B Ratio
4.725.176.254.40.92
PTB ratio
4.725.176.254.40.92
EV to sales
4.2744.123.411.02
Enterprise value over EBITDA
14.2912.1813.7512.524.96
EV to operating cash flow
38.915.9332.1620.555.65
EV to free cash flow
56.718.4843.7625.216.81
Earnings yield
-0.060.0300.060.21
Free cash flow yield
0.020.060.030.050.28
Debt to equity
1.31.161.290.940.98
Debt to assets
0.380.340.350.310.31
Net debt to EBITDA
2.771.942.091.962.38
Current ratio
0.560.770.620.630.64
Interest coverage
-5.468.6614.312.647.44
Income quality
-0.721.63-2.110.781.61
Dividend Yield
0.030.030.030.030.17
Payout ratio
-0.441.05-23.960.540.81
Sales general and administrative to revenue
0.060.10.090.080
Research and developement to revenue
0.020.020.020.020
Intangibles to total assets
0.750.730.70.70.17
Capex to operating cash flow
-0.31-0.14-0.27-0.18-0.17
Capex to revenue
-0.03-0.03-0.03-0.03-0.03
Capex to depreciation
-0.08-0.33-0.94-0.73-0.96
Stock based compensation to revenue
0000.010
Graham number
6.824.390.826.2624.66
ROIC
-0.10.10.040.130.1
Return on tangible assets
-0.350.14-0.010.270.07
Graham Net
-5.38-5.11-4.47-4.36-20.73
Working capital
-3.9B-1.62B-3.08B-3.06B-3.04B
Tangible asset value
-14.85B-13.82B-11.42B-10.72B3.89B
Net current asset value
-17.7B-16.82B-14.49B-13.97B-13.37B
Invested capital
1.31.161.290.940.98
Average receivables
1.07B2.09B2.06B2.16B2.19B
Average payables
4.82B5.28B5.5B5.41B5.53B
Average inventory
1.3B1.45B1.53B1.64B1.73B
Days sales outstanding
60.853.3757.3956.4953.52
Days payables outstanding
347.14377.08345.89332.35343.71
Days of inventory on hand
94.63104.5595.81109.34102.19
Receivables turnover
66.846.366.466.82
Payables turnover
1.050.971.061.11.06
Inventory turnover
3.863.493.813.343.57
ROE
-0.30.13-0.010.250.19
Capex per share
-0.13-0.14-0.13-0.12-0.63

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
010.575.1910.390
Net income per share
01.380.861.730
Operating cash flow per share
02.180.651.30
Free cash flow per share
01.810.551.040
Cash per share
01.621.431.160
Book value per share
013.1912.812.820
Tangible book value per share
0-14.98-14.14-14.170
Share holders equity per share
013.1912.812.820
Interest debt per share
012.656.9712.280
Market cap
08.36B8.97B8.63B0
Enterprise value
-1.16B16.09B7.94B16.24B7.15B
P/E ratio
02.113.641.740
Price to sales ratio
01.112.411.160
POCF ratio
05.3619.189.230
PFCF ratio
06.4722.6811.570
P/B Ratio
00.890.980.940
PTB ratio
00.890.980.940
EV to sales
02.132.132.181
Enterprise value over EBITDA
08.527.998.177.06
EV to operating cash flow
010.3216.9917.374.2
EV to free cash flow
012.4620.0821.784.96
Earnings yield
00.120.070.140
Free cash flow yield
00.150.040.090
Debt to equity
0.730.940.540.940.98
Debt to assets
0.240.310.180.310.31
Net debt to EBITDA
04.09-1.033.837.06
Current ratio
0.630.630.540.540.64
Interest coverage
08.74011.14.27
Income quality
01.570.750.764.23
Dividend Yield
00.060.040.090
Payout ratio
00.530.640.641.37
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.70.70.70.70.17
Capex to operating cash flow
0-0.17-0.15-0.2-0.15
Capex to revenue
0-0.04-0.02-0.03-0.04
Capex to depreciation
0-0.7-0.62-0.81-1.1
Stock based compensation to revenue
000.0100
Graham number
020.2715.7222.350
ROIC
00.060.050.070.02
Return on tangible assets
00.120.080.150.02
Graham Net
0-21.67-20.65-20.890
Working capital
-3.06B-3.06B-4.27B-4.27B-3.04B
Tangible asset value
-10.72B-10.72B-10.15B-10.15B3.89B
Net current asset value
-13.97B-13.97B-13.31B-13.31B-13.37B
Invested capital
0.730.940.540.940.98
Average receivables
862M1.98B2.2B2.2B0
Average payables
3.85B3.96B5.26B4.98B0
Average inventory
1.81B1.83B1.74B1.66B0
Days sales outstanding
026.6152.4626.9726.92
Days payables outstanding
0155.18296.57147.6175.41
Days of inventory on hand
051.0698.8249.1852.15
Receivables turnover
03.381.723.343.34
Payables turnover
00.580.30.610.51
Inventory turnover
01.760.911.831.73
ROE
00.10.070.140.05
Capex per share
0-0.37-0.1-0.260

RBGLY Frequently Asked Questions

What is Reckitt Benckiser Group plc stock symbol ?

Reckitt Benckiser Group plc is a GB stock and trading under the symbol RBGLY

What is Reckitt Benckiser Group plc stock quote today ?

Reckitt Benckiser Group plc stock price is $11.15 today.

Is Reckitt Benckiser Group plc stock public?

Yes, Reckitt Benckiser Group plc is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap